Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
BACKGROUND AND OBJECTIVE: Major depressive disorder is a common and destructive mental disorder with relatively long episodes, high tendency to be chronic and recurrence, and responsible for many physical and mental disabilities that has the lifetime prevalence of about 17% to 19%. With regard to th...
Guardado en:
Autores principales: | F Kheirkhah, AA Moghadamnia, G Tayebi, A Bijani, P Tayebi, A Salavati |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05f8e59e778e464abfbea5ee17cbe947 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
por: Muhammad Siddique Kakar, et al.
Publicado: (2020) -
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
por: Mateusz Kowalczyk, et al.
Publicado: (2021) -
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Wei Zheng, et al.
Publicado: (2021) -
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020) -
Predictors of Major Depressive Disorder in Older People
por: Susana Sousa, et al.
Publicado: (2021)